|
Gómez-Simón A, Plaza EM, Torregrosa JM, Ferrer-Marín F, Sánchez-Guiu I, Vicente V, Lozano ML, Rivera J. Evaluation of two-step haemoglobin screening with HemoCue for blood donor qualification in mobile collection sites. Vox Sang. 2014 Nov;107(4):343-50. doi: 10.1111/vox.12165. PubMed PMID: 24916720.
AÑO: 2014; IF: 2.347
|
24916720
|
Ferrer-Marin F, Gutti R, Liu ZJ, Sola-Visner M. MiR-9 contributes to the developmental differences in CXCR-4 expression in human megakaryocytes. J Thromb Haemost. 2014 Feb;12(2):282-5. PubMed PMID: 24738139.
AÑO: 2014
|
|
Gimenez E, Besses C, Boque C, Velez P, Kerguelen A, Cervantes F, Ferrer-Marin F, Perez-Encinas M, Rodriguez M, Gonzalez JD, Calzada R, Hernandez-Boluda JC. Indirect and non-medical economic burden, quality-of-life, and disabilities of the myelofibrosis disease in Spain. J Med Econ. 2014 Jun;17(6):435-41. doi: 10.3111/13696998.2014.903257. PubMed PMID: 24716650.
AÑO: 2014
|
|
Hernández-Boluda JC, Pereira A, Gómez M, Boqué C, Ferrer-Marín F, Raya JM, García-Gutiérrez V, Kerguelen A, Xicoy B, Barba P, Martínez J, Luño E, Alvarez-Larrán A, Martínez-López J, Arbelo E, Besses C; Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas.. The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis. Haematologica. 2014 Apr;99(4):e55-7. doi: 10.3324/haematol.2013.101733. PubMed PMID: 24488561; PubMed Central PMCID: PMC3971095.
AÑO: 2014; IF: 5.814
|
|
Alvarez-Larrán A, Martínez-Avilés L, Hernández-Boluda JC, Ferrer-Marín F, Antelo ML, Burgaleta C, Mata MI, Xicoy B, Martínez-Trillos A, Gómez-Casares MT, Durán MA, Marcote B, Ancochea A, Senín A, Angona A, Gómez M, Vicente V, Cervantes F, Bellosillo B, Besses C. Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea. Ann Hematol. 2014 Dec;93(12):2037-43. doi: 10.1007/s00277-014-2152-7. PubMed PMID: 24981691.
AÑO: 2014; IF: 2.634
|